In the last trading session, 8.39 million Quantum BioPharma Ltd (NASDAQ:QNTM) shares changed hands as the company’s beta touched 0.31. With the company’s per share price at $7.18 changed hands at $2.29 or 46.83% during last session, the market valuation stood at $13.79M. QNTM’s last price was a discount, traded about -581.89% off its 52-week high of $48.96. The share price had its 52-week low at $2.70, which suggests the last value was 62.4% up since then. When we look at Quantum BioPharma Ltd’s average trading volume, we note the 10-day average is 0.94 million shares, with the 3-month average coming to 2.45 million.
Quantum BioPharma Ltd (NASDAQ:QNTM) trade information
Instantly QNTM was in green as seen at the end of in last trading. With action 63.18%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 95.11%, with the 5-day performance at 63.18% in the green. However, in the 30-day time frame, Quantum BioPharma Ltd (NASDAQ:QNTM) is -32.58% down. Looking at the short shares, we see there were 49138.0 shares sold at short interest cover period of 0.01 days.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 31.10%.
QNTM Dividends
Quantum BioPharma Ltd is expected to release its next quarterly earnings report on 2024-Nov-10.
Quantum BioPharma Ltd (NASDAQ:QNTM)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 11.46% of Quantum BioPharma Ltd shares while 14.84% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 16.76%.
